Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species-Reference-Cited by-同舟云学术

Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species

Published:2013-01 Issue:1 Volume:75 Page:89-93
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N.,Flamm Robert K.,Sader Helio S.,Stilwell Matthew G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin;Barry;J Clin Microbiol,1987

2. Performance standards for antimicrobial disk susceptibility tests; approved standard -- 11th edition, M02-A11;Clinical and Laboratory Standards Institute (CLSI),2012

3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard -- ninth edition, M07-A9;Clinical and Laboratory Standards Institute (CLSI),2012

4. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23);Clinical and Laboratory Standards Institute (CLSI),2013

5. Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection;Corey;Clin Infect Dis,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA;Communications Biology;2020-10-22

2. Analysis of Potential β-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae;Journal of Clinical Microbiology;2018-04

3. Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report;Future Microbiology;2017-12

4. Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin;Diagnostic Microbiology and Infectious Disease;2015-05

5. Use of In Vitro Vancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide;Antimicrobial Agents and Chemotherapy;2015-04